Gossamer Bio Inc. [GOSS] Chief Scientific Officer makes an insider purchase of 4,876 shares worth 58868.0.


Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Gossamer Bio Inc. shares valued at $58,868 were sold by Carter Laura on Oct 24. At $12.07 per share, Carter Laura sold 4,876 shares. The insider’s holdings dropped to 82,292 shares worth approximately $0.14 million following the completion of this transaction.

Do You Know The Best Place To Find Gains In Volatile Markets?

In today's chaotic marketplace, the biggest gains will come from some currently-small companies that pass by older, larger businesses still stuck in a pre-pandemic world. The trick is figuring out which small caps will be tomorrow's winners. That's why StockWire News has put together a special Wealth Building Report, highlighting 3 small cap stocks set to soar in 2023.

Click here for full details and to join for free.


Also, Aranda Richard sold 4,757 shares, netting a total of over 57,431 in proceeds. Following the sale of shares at $12.07 each, the insider now holds 205,430 shares.

Before that, Peterson Caryn had sold 4,757 shares from its account. In a trade valued at $57,431, the EVP, Regulatory Affairs traded Gossamer Bio Inc. shares for $12.07 each. Upon closing the transaction, the insider’s holdings decreased to 4,757 shares, worth approximately $0.11 million.

As published in their initiating research note from Guggenheim on March 01, 2023, Gossamer Bio Inc. [GOSS] has been a Neutral. Analysts at SMBC Nikko downgraded the stock from ‘”an Outperform”‘ to ‘”a Neutral”‘ outlook in a report released in early December. As of December 07, 2022, JP Morgan has decreased its “Neutral” rating to a “an Underweight” for GOSS. Earlier on December 07, 2022, Barclays downgraded its rating. Their new recommendation was “an Equal weight” for GOSS stock which previously was a “an Overweight”.

Analyzing GOSS Stock Performance

On Thursday, Gossamer Bio Inc. [NASDAQ: GOSS] rose 6.02% to $1.76. The stock’s lowest price that day was $1.62, but it reached a high of $1.83 in the same session. During the last five days, there has been a surge of approximately 1.15%. Over the course of the year, Gossamer Bio Inc. shares have dropped approximately -18.89%. Shares of the company reached a 52-week high of $3.0599 on 02/02/23 and a 52-week low of $1.5800 on 03/01/23. A 50-day SMA is recorded $2.1806, while a 200-day SMA reached $8.1844. Nevertheless, trading volume fell to 2.84 million shares from 2.96 million shares the previous day.

Support And Resistance Levels for Gossamer Bio Inc. (GOSS)

According to the 24-hour chart, there is a support level at 1.6433, which, if violated, would cause prices to drop to 1.5267. In the upper region, resistance lies at 1.8533. The next price resistance is at 1.9467. RSI (Relative Strength Index) is 34.40 on the 14-day chart, showing neutral technical sentiment. Moving Average Convergence Divergence (MACD) is at -0.2640, which suggests the price will decrease in the coming days. Percent R is at 81.05%, indicating bearish price movement. Stochastics %K at buying indicates that the stock is to be held.

Is Gossamer Bio Inc. subject to short interest?

Stocks of Gossamer Bio Inc. saw a sharp steep in short interest on Jan 30, 2023 dropping by -1.54 million shares to 25.35 million. Data from Yahoo Finance shows that the short interest on Dec 29, 2022 was 26.89 million shares. A decline of -6.07% in short interest reflects a negative sentiment towards the stock. Despite the fact that short shares comprise just 6.89 of the overall float, the days-to-cover ratio (short ratio) decline to 6.89.

Which companies own the most shares of Gossamer Bio Inc. (GOSS)?

According to SSgA Funds Management, Inc. filings, the company currently owns 27,843,985 shares, which is about 29.47% of the total GOSS shares outstanding. The investor’s shares have appreciated by 24,066,082 from its previous 13-F filing of 3777903.0 shares. With the completion of the buy transaction, The Vanguard Group, Inc.’s stake is now worth $20,591,358. HHLR Advisors Ltd. reduced a -32.97% interest valued at $13.13 million while BlackRock Fund Advisors purchased a 183,858 stake. A total of 3,296,396 shares of Gossamer Bio Inc. were bought by Millennium Management LLC during the quarter, and 869,250 were bought by Weiss Asset Management LP. In its current portfolio, Invus Public Equities Advisors LL holds 3,246,624 shares valued at $8.57 million.


Please enter your comment!
Please enter your name here